Clinical Oncology
Volume 20, Issue 1 , Pages 22-30 , February 2008

Practical Issues in the Implementation of Image-guided Radiotherapy for the Treatment of Prostate Cancer within a UK Department

  • Y.L. Rimmer

      Affiliations

    • Oncology Centre, Addenbrooke's Hospital, Cambridge, UK
    • Corresponding Author InformationAuthor for correspondence: Y. L. Rimmer, Oncology Centre, Box 193, Addenbrooke's Hospital, Hills Road, Cambridge CB2 2QQ, UK.
    • ,
  • N.G. Burnet

      Affiliations

    • University of Cambridge Department of Oncology, Addenbrooke's Hospital, Cambridge, UK
    • ,
  • D.S. Routsis

      Affiliations

    • Oncology Centre, Addenbrooke's Hospital, Cambridge, UK
    • ,
  • N. Twyman

      Affiliations

    • Department of Medical Physics, Addenbrooke's Hospital, Cambridge, UK
    • ,
  • A.C.F. Hoole

      Affiliations

    • Department of Medical Physics, Addenbrooke's Hospital, Cambridge, UK
    • ,
  • J. Treeby

      Affiliations

    • Oncology Centre, Addenbrooke's Hospital, Cambridge, UK
    • ,
  • D. Welford

      Affiliations

    • Oncology Centre, Addenbrooke's Hospital, Cambridge, UK
    • ,
  • J. Fairfoul

      Affiliations

    • Department of Medical Physics, Addenbrooke's Hospital, Cambridge, UK
    • ,
  • T. ‘Aho

      Affiliations

    • Department of Urology, Addenbrooke's Hospital, Cambridge, UK
    • ,
  • S.L. Vowler

      Affiliations

    • Centre for Applied Medical Statistics, Department of Public Health and Primary Care, University of Cambridge, UK
    • ,
  • R.J. Benson

      Affiliations

    • Oncology Centre, Addenbrooke's Hospital, Cambridge, UK

Received 5 July 2007 ,Revised 20 August 2007 ,Accepted 3 October 2007.

References 

  1. Hanks GE, Hanlon AL, Epstein B, Horwitz EM. Dose response in prostate cancer with 8–12 years' follow-up. Int J Radiat Oncol Biol Phys. 2002;54(2):427–435
  2. Pollack A, Zagars GK, Starkschall G, et al. Prostate cancer radiation dose response: results of the M.D. Anderson phase III randomized trial. Int J Radiat Oncol Biol Phys. 2002;53(5):1097–1105
  3. Valicenti RK, Gomella LG. Durable efficacy of adjuvant radiation therapy for prostate cancer: will the benefit last?. Semin Urol Oncol. 2000;18(2):115–120
  4. Ten Haken RK, Forman JD, Heimburger DK, et al. Treatment planning issues related to prostate movement in response to differential filling of the rectum and bladder. Int J Radiat Oncol Biol Phys. 1991;20(6):1317–1324
  5. van Herk M, Bruce A, Kroes AP, Shouman T, Touw A, Lebesque JV. Quantification of organ motion during conformal radiotherapy of the prostate by three dimensional image registration. Int J Radiat Oncol Biol Phys. 1995;33(5):1311–1320
  6. Dawson LA, Mah K, Franssen E, Morton G. Target position variability throughout prostate radiotherapy. Int J Radiat Oncol Biol Phys. 1998;42(5):1155–1161
  7. Roeske JC, Forman JD, Mesina CF, et al. Evaluation of changes in the size and location of the prostate, seminal vesicles, bladder, and rectum during a course of external beam radiation therapy. Int J Radiat Oncol Biol Phys. 1995;33(5):1321–1329
  8. Nederveen AJ, van der Heide UA, Dehnad H, van Moorselaar RJ, Hofman P, Lagendijk JJ. Measurements and clinical consequences of prostate motion during a radiotherapy fraction. Int J Radiat Oncol Biol Phys. 2002;53(1):206–214
  9. Aubry JF, Beaulieu L, Girouard LM, et al. Measurements of intrafraction motion and interfraction and intrafraction rotation of prostate by three-dimensional analysis of daily portal imaging with radiopaque markers. Int J Radiat Oncol Biol Phys. 2004;60(1):30–39
  10. Hanley J, Lumley MA, Mageras GS, et al. Measurement of patient positioning errors in three-dimensional conformal radiotherapy of the prostate. Int J Radiat Oncol Biol Phys. 1997;37(2):435–444
  11. Bel A, Bartelink H, Vijlbrief RE, Lebesque JV. Transfer errors of planning CT to simulator: a possible source of setup inaccuracies?. Radiother Oncol. 1994;31(2):176–180
  12. Creutzberg CL, Althof VG, de Hoog MD, et al. A quality control study of the accuracy of patient positioning in irradiation of pelvic fields. Int J Radiat Oncol Biol Phys. 1996;34(3):697–708
  13. Dearnaley DP, Khoo VS, Norman AR, et al. Comparison of radiation side-effects of conformal and conventional radiotherapy in prostate cancer: a randomised trial. Lancet. 1999;353(9149):267–272
  14. Koper PC, Stroom JC, van Putten WL, et al. Acute morbidity reduction using 3DCRT for prostate carcinoma: a randomized study. Int J Radiat Oncol Biol Phys. 1999;43(4):727–734
  15. Zelefsky MJ, Fuks Z, Happersett L, et al. Clinical experience with intensity modulated radiation therapy (IMRT) in prostate cancer. Radiother Oncol. 2000;55(3):241–249
  16. Dearnaley DP, Sydes MR, Graham JD, et al. Escalated-dose versus standard-dose conformal radiotherapy in prostate cancer: first results from the MRC RT01 randomised controlled trial. Lancet Oncol. 2007;8(6):475–487
  17. Schallenkamp JM, Herman MG, Kruse JJ, Pisansky TM. Prostate position relative to pelvic bony anatomy based on intraprostatic gold markers and electronic portal imaging. Int J Radiat Oncol Biol Phys. 2005;63(3):800–811
  18. Smitsmans MH, Wolthaus JW, Artignan X, et al. Automatic localization of the prostate for on-line or off-line image-guided radiotherapy. Int J Radiat Oncol Biol Phys. 2004;60(2):623–635
  19. Moseley DJ, White EA, Wiltshire KL, et al. Comparison of localization performance with implanted fiducial markers and cone-beam computed tomography for on-line image-guided radiotherapy of the prostate. Int J Radiat Oncol Biol Phys. 2007;67(3):942–953
  20. Herman MG, Pisansky TM, Kruse JJ, Prisciandaro JI, Davis BJ, King BF. Technical aspects of daily online positioning of the prostate for three-dimensional conformal radiotherapy using an electronic portal imaging device. Int J Radiat Oncol Biol Phys. 2003;57(4):1131–1140
  21. Artignan X, Smitsmans MH, Lebesque JV, Jaffray DA, van Her M, Bartelink H. Online ultrasound image guidance for radiotherapy of prostate cancer: impact of image acquisition on prostate displacement. Int J Radiat Oncol Biol Phys. 2004;59(2):595–601
  22. Langen KM, Pouliot J, Anezinos C, et al. Evaluation of ultrasound-based prostate localization for image-guided radiotherapy. Int J Radiat Oncol Biol Phys. 2003;57(3):635–644
  23. Willoughby TR, Kupelian PA, Pouliot J, et al. Target localization and real-time tracking using the Calypso 4D localization system in patients with localized prostate cancer. Int J Radiat Oncol Biol Phys. 2006;65(2):528–534
  24. Herman MG. Clinical use of electronic portal imaging. Semin Radiat Oncol. 2005;15(3):157–167
  25. Delaney GP, Gebski V, Lunn AD, et al. An assessment of the Basic Treatment Equivalent (BTE) model as measure of radiotherapy workload. Clin Oncol (R Coll Radiol). 1997;9(4):240–244
  26. Burnet NG, Routsis DS, Murrell P, et al. A tool to measure radiotherapy complexity and workload: derivation from the basic treatment equivalent (BTE) concept. Clin Oncol (R Coll Radiol). 2001;13(1):14–23
  27. Radiology WPotBIo . Geometrical uncertainties. Defining the planning target volume. British Institute of Radiology; 2003;
  28. Ghilezan MJ, Jaffray DA, Siewerdsen JH, et al. Prostate gland motion assessed with cine-magnetic resonance imaging (cine-MRI). Int J Radiat Oncol Biol Phys. 2005;62(2):406–417
  29. Hoogeman MS, van Herk M, de Bois J, Lebesque JV. Strategies to reduce the systematic error due to tumor and rectum motion in radiotherapy of prostate cancer. Radiother Oncol. 2005;74(2):177–185
  30. Kupelian PA, Willoughby TR, Meeks SL, et al. Intraprostatic fiducials for localization of the prostate gland: monitoring intermarker distances during radiation therapy to test for marker stability. Int J Radiat Oncol Biol Phys. 2005;62(5):1291–1296
  31. Pouliot J, Morin O, Aubin M, et al. Megavoltage cone-beam CT: recent developments and clinical applications. Cancer Radiother. 2006;10(5):258–268
  32. Soete G, De Cock M, Verellen D, Michielsen D, Keuppens F, Storme G. X-ray-assisted positioning of patients treated by conformal arc radiotherapy for prostate cancer: comparison of setup accuracy using implanted markers versus bony structures. Int J Radiat Oncol Biol Phys. 2007;67(3):823–827
  33. van Herk M. Errors and margins in radiotherapy. Semin Radiat Oncol. 2004;14(1):52–64
  34. Crook JM, Raymond Y, Salhani D, Yang H, Esche B. Prostate motion during standard radiotherapy as assessed by fiducial markers. Radiother Oncol. 1995;37(1):35–42
  35. Poggi MM, Gant DA, Sewchand W, Warlick WB. Marker seed migration in prostate localization. Int J Radiat Oncol Biol Phys. 2003;56(5):1248–1251
  36. Dehnad H, Nederveen AJ, van der Heide UA, van Moorselaar RJ, Hofman P, Lagendijk JJ. Clinical feasibility study for the use of implanted gold seeds in the prostate as reliable positioning markers during megavoltage irradiation. Radiother Oncol. 2003;67(3):295–302
  37. van der Heide UA, Kotte AN, Dehnad H, Hofman P, Lagenijk JJ, van Vulpen M. Analysis of fiducial marker-based position verification in the external beam radiotherapy of patients with prostate cancer. Radiother Oncol. 2007;82(1):38–45
  38. Langen KM, Jones DT. Organ motion and its management. Int J Radiat Oncol Biol Phys. 2001;50(1):265–278
  39. Mah D, Freedman G, Milestone B, et al. Measurement of intrafractional prostate motion using magnetic resonance imaging. Int J Radiat Oncol Biol Phys. 2002;54(2):568–575
  40. Kaiser A, Schultheiss TE, Wong JY, et al. Pitch, roll, and yaw variations in patient positioning. Int J Radiat Oncol Biol Phys. 2006;66(3):949–955
  41. Rasch C, Steenbakkers R, van Herk M. Target definition in prostate, head, and neck. Semin Radiat Oncol. 2005;15(3):136–145
  42. Chung PW, Haycocks T, Brown T, et al. On-line aSi portal imaging of implanted fiducial markers for the reduction of interfraction error during conformal radiotherapy of prostate carcinoma. Int J Radiat Oncol Biol Phys. 2004;60(1):329–334

PII: S0936-6555(07)00832-1

doi: 10.1016/j.clon.2007.10.001

Clinical Oncology
Volume 20, Issue 1 , Pages 22-30 , February 2008

Article Tools

* Image Usage & Resolution